
Keywords: siRNA; ARDS; acute respiratory distress syndrome; ALI; acute lung injury; ICU; intensive care unit; LPS; lipopolysaccharide; EC; endothelial cells; HPAECs; human pulmonary artery endothelial cells; NF-kB; nuclear factor kappa-light-chain-enhancer of activated BÂ